ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 107 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,763 | -14.5% | 14,046 | +20.2% | 0.00% | -33.3% |
| Q2 2023 | $329,577 | +44.9% | 11,683 | -11.7% | 0.00% | +50.0% |
| Q1 2023 | $227,522 | -12.2% | 13,228 | +2.8% | 0.00% | -33.3% |
| Q4 2022 | $259,061 | -3.3% | 12,863 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $268,000 | -22.8% | 12,383 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $347,000 | +22.6% | 12,349 | +101.7% | 0.00% | +50.0% |
| Q1 2022 | $283,000 | -44.5% | 6,123 | +1.0% | 0.00% | -50.0% |
| Q4 2021 | $510,000 | +36.0% | 6,063 | +7.7% | 0.00% | +33.3% |
| Q3 2021 | $375,000 | +27.6% | 5,627 | +1.9% | 0.00% | +50.0% |
| Q2 2021 | $294,000 | +27.3% | 5,520 | +3.8% | 0.00% | 0.0% |
| Q1 2021 | $231,000 | -14.8% | 5,320 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $271,000 | – | 5,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |